National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff; Modifications to the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM), Supplementary Classification of External Causes of Injury and Poisoning, 46299-46300 [E8-18284]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 154 / Friday, August 8, 2008 / Notices
Dated: July 24, 2008.
Penelope Slade Royall,
RADM, USPHS, Deputy Assistant Secretary
for Health, (Disease Prevention and Health
Promotion).
[FR Doc. E8–18299 Filed 8–7–08; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Preparedness,
Detection, and Control of Infectious
Diseases
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting.
pwalker on PROD1PC71 with NOTICES
Name: Clinical Laboratory Improvement
Advisory Committee (CLIAC).
Times and Dates: 8:30 a.m.–5 p.m.,
September 10, 2008; 8:30 a.m.–3 p.m.,
September 11, 2008.
Place: Centers for Disease Control and
Prevention, 1600 Clifton Road, NE., Tom
Harkin Global Communications Center,
Building 19, Room 232, Auditorium B,
Atlanta, Georgia 30333.
New Information—Online Registration
Required: In order to expedite security
clearance process at the CDC Roybal Campus
located on Clifton Road, all CLIAC attendees
are required to register in advance for the
meeting at https://www.cdc.gov/cliac/
default.aspx by clicking the Register for a
‘‘Meeting’’ link and completing all forms
according to the instructions given. Please
complete all the required fields and submit
your registration as far in advance of the
meeting date as possible.
Note: The cut-off date for registration for
domestic attendees is Thursday, September
4, 2008; the cut-off date for international
attendees to register is Monday, August 25,
2008.
Status: Open to the public, limited only by
the space available. The meeting Room
accommodates approximately 100 people.
Purpose: This Committee is charged with
providing scientific and technical advice and
guidance to the Secretary of Health and
Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the
need for, and the nature of, revisions to the
standards under which clinical laboratories
are regulated; the impact on medical and
laboratory practice of proposed revisions to
the standards; and the modification of the
standards to accommodate technological
advances.
Matters to Be Discussed: The agenda will
include updates from the CDC, the Centers
for Medicare & Medicaid Services, and the
Food and Drug Administration; a report from
the CLIAC Workgroup on Good Laboratory
Practices for Genetic Testing, and discussion
VerDate Aug<31>2005
17:25 Aug 07, 2008
Jkt 214001
of the Workgroup’s proposals related to such;
presentations and discussion related to
laboratory quality control through risk
management; and an introduction to the
status of waived testing and discussion of the
potential for waiver of automated hematology
devices. Agenda items are subject to change
as priorities dictate.
Providing Oral or Written Comments: It is
the policy of CLIAC to accept written public
comments and provide a brief period for oral
public comments whenever possible.
Oral Comments: In general, each
individual or group requesting to make an
oral presentation will be limited to a total
time of five minutes (unless otherwise
indicated). Speakers must also submit their
comments in writing for inclusion in the
meeting’s Summary Report. To assure
adequate time is scheduled for public
comments, individuals or groups planning to
make an oral presentation should, when
possible, notify the contact person below at
least one week prior to the meeting date.
Written Comments: For individuals or
groups unable to attend the meeting, CLIAC
accepts written comments until the date of
the meeting (unless otherwise stated).
However, the comments should be received
at least one week prior to the meeting date
so that the comments may be made available
to the Committee for their consideration and
public distribution. Written comments, one
hard copy with original signature, should be
provided to the contact person below.
Written comments will be included in the
meeting’s Summary Report.
Contact Person for Additional Information:
Nancy Anderson, Chief, Laboratory Practice
Standards Branch, Division of Laboratory
Systems, National Center for Preparedness,
Detection, and Control of Infectious Diseases,
Coordinating Center for Infectious Diseases,
CDC, 1600 Clifton Road, NE., Mailstop F–11,
Atlanta, Georgia 30333; telephone (404) 498–
2741; fax (404) 498–2219; or via e-mail at
Nancy.Anderson@cdc.hhs.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
CDC and the Agency for Toxic Substances
and Disease Registry.
Dated: July 28, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–18285 Filed 8–7–08; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
46299
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Health Statistics
(NCHS), Classifications and Public
Health Data Standards Staff;
Modifications to the International
Classification of Diseases, Ninth
Revision, Clinical Modification (ICD–9–
CM), Supplementary Classification of
External Causes of Injury and
Poisoning
ACTION:
Notice.
National Center for Health Statistics
(NCHS), Classifications and Public
Health Data Standards Staff, announces
the following modifications to the
International Classification of Diseases,
Ninth Revision, Clinical Modification
(ICD–9–CM), Supplementary
Classification of External Causes of
Injury and Poisoning. These codes will
become effective October 1, 2008.
External Cause Tabular
New code E927.0 Overexertion from
sudden strenuous movement. Sudden
trauma from strenuous movement
New code E927.1 Overexertion from
prolonged static position
New code E927.2 Excessive physical
exertion from prolonged activity
New code E927.3 Cumulative trauma
from repetitive motion
New code E927.4 Cumulative trauma
from repetitive impact
New code E927.8 Other overexertion
and strenuous and repetitive
movements or loads
New code E927.9 Unspecified
overexertion and strenuous and
repetitive movements or loads
CONTACT PERSON FOR ADDITIONAL
INFORMATION: Donna Pickett, Medical
Systems Specialist, Classifications and
Public Health Data Standards Staff,
NCHS, 3311 Toledo Road, Room 2402,
Hyattsville, Maryland 20782, e-mail
dfp4@cdc.gov, telephone 301–458–4434.
The complete diagnosis addenda may be
accessed on the NCHS Web site using
the URL: https://www.cdc.gov/nchs/
datawh/ftpserv/ftpicd9/
ftpicd9.htm#addenda.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to modifications to
the ICD–9–CM, for both CDC and the
E:\FR\FM\08AUN1.SGM
08AUN1
46300
Federal Register / Vol. 73, No. 154 / Friday, August 8, 2008 / Notices
Agency for Toxic Substances and
Disease Registry.
Daniel Riedford,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E8–18284 Filed 8–7–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
pwalker on PROD1PC71 with NOTICES
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 73 FR 35140, dated
June 20, 2008) is amended to reflect the
reorganization of the Office of the
Director, Centers for Disease Control
and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows: Delete in their entirety the titles
and functional statements for the Office
of Strategy and Innovation (CAM) and
the Office of Chief of Public Health
Practice (CAR) and insert the following:
Office of Strategy and Innovation
(CAM). The Office of Strategy and
Innovation (OSI) serves as the focal
point for accelerating the health impact
of CDC’s work within and beyond CDC’s
programs. In carrying out its mission,
OSI: (1) Leads CDC’s efforts to develop,
monitor, evaluate, and advance agency
strategic direction, planning, and
priorities; (2) fosters strategic excellence
and innovation across the agency; (3)
provides superior decision support to
CDC’s executive leadership; (4) leads
the development of health in all
policies; (5) promotes the health, safety,
and quality of life of women; and (6)
improves the health of the public
through law.
Office of the Director (CAM1). (1)
Develops, monitors, and advances
CDC’s strategic direction, planning, and
priorities; (2) provides leadership and
vision for formulating and evaluating
policy; (3) fosters strategic excellence
and innovation across the agency; (4)
applies knowledge management tools
and decision support systems in
allocation of resources and improves
agency decision-making; (5)
communicates key messages to CDC
VerDate Aug<31>2005
17:25 Aug 07, 2008
Jkt 214001
employees and partners about CDC’s
strategic direction, planning, and
priorities; and (6) works directly with
the strategy and innovation officers
within the coordinating centers to
develop, monitor, and advance CDC
strategic direction and priorities and
institutionalize organizational change,
improvement, and accountability.
Office of Women’s Health (CAM12).
The Office of Women’s Health (OWH)
aims to promote and improve the
health, safety, and quality of life of
women. As a leader for women’s health
issues at CDC, the Office of Women’s
Health: (1) Advises the CDC Director on
matters relating to women’s health
research, programs, and strategies; (2)
promotes the health and well-being of
women; (3) communicates health
information, research findings, and
prevention strategies to a diverse group
of providers, consumers, and
organizations; (4) advances sound
scientific knowledge for public health
action, promotes the role of prevention,
and works to improve the
understanding of women’s health
priorities; (5) fosters partnerships and
collaborations within CDC and with
other public and private organizations,
agencies, institutions, and others to
improve the health and safety of
women; (6) publishes newsletters and
other documents that highlight
prevention programs, research findings,
publications, health campaigns, health
promotion strategies, and other
information available at CDC; (7) leads
CDC Women’s Health Committee by
facilitating and coordinating agencywide efforts and enhancing channels for
communication and cooperation; (8)
supports the development of future
women’s health and public health
professionals through various training
and student positions within the office;
(9) prepares agency reports, briefing
documents, and other materials
addressing women’s health issues; (10)
stimulates and supports prevention
research, programs, and other activities
through funding; (11) represents the
agencies at meetings, committees,
workgroups, conferences, and briefings;
(12) serves as liaison for women’s health
between CDC and other agencies and
organizations; (13) develops
opportunities for, promotes, and
supports the agency as a resource for
women’s health issues; and (14)
provides assistance to state and local
programs on women’s health issues.
Public Health Law Program (CAM13).
The mission of the Public Health Law
Program is to improve the health of the
public through law. The program: (1)
Provides technical assistance to CDC
centers and to extramural partners in
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
developing their legal preparedness to
address the full spectrum of health
protection goals; (2) collaborates with
CDC and extramural partners in
developing tools for use in assessing
and improving the public health legal
preparedness of the health system; (3)
strengthens the competencies of
practitioners in public health,
emergency management, law, and other
sectors to apply law to improve public
health; (4) supports and conducts
applied research in public health law
and translates findings into practice; (5)
provides consultation and analysis in
public health law to CDC programs and
extramural constituents; (6) establishes
partnerships among CDC and other
organizations active in public health
law and assists in strengthening their
public health law capacity and
expertise; and (7) develops and
disseminates authoritative information
on public health law and public health
law best practices to practitioners and
policy makers.
Office of Chief of Public Health
Practice (CAR). The Office of Chief of
Public Health Practice (OCPHP) serves
as the advocate, guardian, promoter, and
conscience of public health practice
throughout CDC and in the larger public
health community; ensures coordination
and synergy of CDC’s scientific and
practice activities; and promotes and
protects the public’s health through
science-based, practice-relevant
standards, policies, and legal tools. To
carry out its mission, OCPHP: (1)
Establishes robust partnerships among
CDC programs, public health
practitioners and key sectors, including
elected officials, the legal community,
and law enforcement and emergency
response organizations; (2) establishes a
functional area focused specifically on
standards and improvement in practice
among state and local public health
systems; (3) advances the development
and implementation of a national
agency accreditation system; (4) relates
relevant research and policy analysis to
public health practice; (5) monitors and
anticipates public health practice trends
and issues; and (6) coordinates and
addresses cross-cutting issues related to
public health practice within CDC; and
(7) develops, monitors and advances
agency-wide goals for improving health
equity, fostering strategic excellence and
innovation across CDC, and
organizational development and the
transition process.
E:\FR\FM\08AUN1.SGM
08AUN1
]]>Agencies
[Federal Register Volume 73, Number 154 (Friday, August 8, 2008)]
[Notices]
[Pages 46299-46300]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-18284]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Center for Health Statistics (NCHS), Classifications and
Public Health Data Standards Staff; Modifications to the International
Classification of Diseases, Ninth Revision, Clinical Modification (ICD-
9-CM), Supplementary Classification of External Causes of Injury and
Poisoning
ACTION: Notice.
-----------------------------------------------------------------------
National Center for Health Statistics (NCHS), Classifications and
Public Health Data Standards Staff, announces the following
modifications to the International Classification of Diseases, Ninth
Revision, Clinical Modification (ICD-9-CM), Supplementary
Classification of External Causes of Injury and Poisoning. These codes
will become effective October 1, 2008.
External Cause Tabular
New code E927.0 Overexertion from sudden strenuous movement. Sudden
trauma from strenuous movement
New code E927.1 Overexertion from prolonged static position
New code E927.2 Excessive physical exertion from prolonged activity
New code E927.3 Cumulative trauma from repetitive motion
New code E927.4 Cumulative trauma from repetitive impact
New code E927.8 Other overexertion and strenuous and repetitive
movements or loads
New code E927.9 Unspecified overexertion and strenuous and repetitive
movements or loads
Contact Person for Additional Information: Donna Pickett, Medical
Systems Specialist, Classifications and Public Health Data Standards
Staff, NCHS, 3311 Toledo Road, Room 2402, Hyattsville, Maryland 20782,
e-mail dfp4@cdc.gov, telephone 301-458-4434. The complete diagnosis
addenda may be accessed on the NCHS Web site using the URL: https://
www.cdc.gov/nchs/datawh/ftpserv/ftpicd9/ftpicd9.htm#addenda.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
modifications to the ICD-9-CM, for both CDC and the
[[Page 46300]]
Agency for Toxic Substances and Disease Registry.
Daniel Riedford,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E8-18284 Filed 8-7-08; 8:45 am]
BILLING CODE 4163-18-P
